Immediate Impact

2 by Nobel laureates 3 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
4 intermediate papers

Works of Mitchell Kaye being referenced

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
2020
Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON
2018

Author Peers

Author Last Decade Papers Cites
Mitchell Kaye 295 158 43 49 10 396
Sonja Bobic 183 125 9 11 15 431
Marlène Murris 232 229 67 19 10 393
E. E. Sproul 125 59 38 11 16 400
Britta Lötstedt 54 55 22 29 9 376
Gaoyun Yang 84 177 15 4 9 395
Vandy P. Stober 174 50 8 12 14 455
Albert C. Sek 43 58 17 15 11 390
Sophia P. Karabela 218 23 24 8 10 354
Noel Rose 57 113 63 6 14 441
FA Kuypers 72 257 10 7 9 450

All Works

Loading papers...

Rankless by CCL
2026